For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Creative Biomolecules, Inc.

USPTO Granted Patents = 71

CIPO Patents = 1

Forward Citations = 3,501

Loading Chart...

Loading Chart...

55 inventors (with patents filed for the assignee):

Hermann Oppermann (41 out of 88 patents)

Charles M Cohen (29 out of 60 patents)

David C Rueger (22 out of 83 patents)

4. Thangavel Kuberasampath (22 out of 67 patents)

5. Roy H Pang (20 out of 26 patents)

6. James S Huston (17 out of 25 patents)

7. Engin Ozkaynak (12 out of 46 patents)

8. Kuber T Sampath (10 out of 46 patents)

9. John E Smart (10 out of 19 patents)

10. Peter C Keck (8 out of 18 patents)

11. Marc F Charette (7 out of 13 patents)

12. Roberto Crea (6 out of 10 patents)

13. Haimanti Dorai (6 out of 6 patents)

14. Richard J Ridge (5 out of 8 patents)

15. David B Ring (3 out of 33 patents)

Core Competencies:

Morphogen Analogs

Inflammatory Response Modulation

Morphogen Treatment

Osteogenic Modulators

Gastrointestinal Ulcers

Liver Regeneration

Protein Production

Biosynthetic Binding Proteins

Tissue Regeneration

Cell Surface Receptors

Platelet Derived Growth Factor

71 patents: Sort by Forward Citations

1. 6273598 - Computer system and methods for producing morphogen analogs of human OP-1 (2001-08-14),

2. 6194376 - Method for modulating inflammatory response comprising administering morphogen (2001-02-27),

3. 6110460 - Methods of using morphogen analogs (2000-08-29),

4. 6103491 - Methods and compositions for identifying morphogen analogs (2000-08-15),

5. 6093547 - Morphogen cell surface receptor and screening for morphogen analogs (2000-07-25),

6. 6090776 - Morphogen treatment of organ implants (2000-07-18),

7. 6090544 - Methods and compositions for identifying morphogen analogs (2000-07-18),

8. 6077823 - Method for reducing tissue damage associated with ischemia-reperfusion (2000-06-20),

9. 6071695 - Methods and products for identification of modulators of osteogenic (2000-06-06),

10. 6022853 - Morphogen-enriched dietary composition (2000-02-08),

11. 5994131 - Morphogenic protein screening method (1999-11-30),

12. 5972884 - Morphogen treatment of gastrointestinal ulcers (1999-10-26),

13. 5968752 - Method for identifying an OP-1 analog which binds an ALK-1 receptor (1999-10-19),

14. 5932716 - Morphogen-responsive regulatory elements (1999-08-03),

15. 5928940 - Morphogen-responsive signal transducer and methods of use thereof (1999-07-27),

Creative BioMolecules, Inc. is a biotechnology company at the forefront of innovative research and development in the field of life sciences. With a focus on the discovery and development of novel therapeutic molecules, the company is dedicated to improving human healthcare. With a team of experienced scientists and cutting-edge technologies, Creative BioMolecules aims to deliver breakthrough solutions in drug discovery, diagnostics, and biotechnology applications. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

71 Patents

#35 in Boston, MA

#279 in Massachusetts

#4,945 in US

#10,065 in the World

Boston, MA, United States of America

Creative Biomolecules, Inc.

Forward Citations = 3,501

55 inventors:

Hermann Oppermann (41 out of 88 patents)

Charles M Cohen (29 out of 60 patents)

David C Rueger (22 out of 83 patents)

4. Thangavel Kuberasampath (22 out of 67 patents)

5. Roy H Pang (20 out of 26 patents)

Please report any incorrect information to support@idiyas.com

Loading…